Axon Enterprise Trades Near 52-Week High: Should You Buy Now or Wait?

Axon Enterprise (AXON) is trading near its 52-week high, having surged 27.7% YTD, driven by strong growth in its Connected Devices and Software & Services segments, with revenues increasing 26.1% and 39% respectively in Q1 2025. Increased demand for TASER 10 products and Axon Body 4 cameras, along with a new partnership with Skydio for drone solutions, led Axon to raise its 2025 revenue guidance to $2.60-$2.70 billion; however, escalating costs and a high forward P/E ratio of 112.59x present near-term concerns.

Analysis

Axon Enterprise (AXON) has demonstrated significant stock appreciation, surging 27.7% year-to-date and trading near its 52-week high of $765.00, thereby outperforming its sub-industry's 14.4% growth and the S&P 500's 0.1% growth. This performance is supported by its shares trading above both 50-day and 200-day moving averages, indicating robust upward momentum and positive market sentiment. Key growth catalysts include the Connected Devices segment, which saw a 26.1% year-over-year revenue increase in Q1 2025, fueled by strong demand for its next-generation TASER 10 products and the new Axon Body 4 camera, shipments of which began in June 2023. Concurrently, the Software & Services segment reported a 39% revenue jump in Q1 2025, building on a 33.4% increase in 2024, driven by digital evidence management, premium feature adoption, and expanding annual recurring revenues (ARR). Reflecting this operational strength, Axon raised its 2025 revenue guidance to $2.60-$2.70 billion, implying approximately 27% year-over-year growth at the midpoint. Furthermore, a strategic partnership in June 2024 with Skydio, a U.S. drone manufacturer, aims to bolster its public safety drone offerings and strengthen its market position. The company's financial health is underscored by a superior trailing 12-month ROE of 21.98% compared to the industry's 11.08%, and upward revisions in earnings estimates for 2025 (EPS $6.15, +3.5% YOY) and 2026 (EPS $7.55, +22.8% YOY). However, challenges persist with escalating operating costs—cost of sales rose 39% in 2024 and 18.2% in Q1 2025, while Q1 selling, general and administrative expenses increased 48% year-over-year. Coupled with a high forward 12-month price-to-earnings (P/E) ratio of 112.59X, significantly above the industry average of 42.04X, these factors temper the near-term outlook despite strong long-term growth prospects, aligning with its Zacks Rank #3 (Hold).

Key Decisions for Investors

• Given Axon's robust growth drivers, product innovation, and expanding market presence, existing investors may consider holding their positions to capitalize on long-term potential, despite near-term headwinds from costs and valuation.
• Prospective investors should exercise caution due to the stock's significantly elevated valuation, with a forward P/E of 112.59X, and the ongoing pressure from escalating operating expenses, potentially awaiting a more attractive entry point or clear evidence of margin stabilization.
• Investors should closely monitor Axon's ability to manage cost inflation, the growth trajectory of its Software & Services annual recurring revenue, and the successful integration and market penetration of new strategic initiatives, such as the Skydio drone partnership, as key indicators of future performance.